← Back

Wire · opportunities

Boston Scientific recalls spinal cord implant in wake of more than 1k serious injuries

Published

8 September 2026

Topic

opportunities

Sectors

Medtech

Geography

United States

Source

Read at fiercebiotech.com

Verified

Fusion42 · 8 September 2026 · Fusion42 review

Boston Scientific has recalled its Infinion CX Lead spinal cord implant due to risk of breakage, linked to over 1,000 serious injuries reported to the FDA. The recall affects unused devices in the United States and signals increased regulatory scrutiny and operational challenges for the company.

This Wire brief sits within Fusion42's coverage of Medtech, and 2 sources have reported it between 5 Sep 2026 and 8 Sep 2026.

◆ The Wire takeaway

You face a tightening FDA risk environment that could delay product launches or slow sales; immediate review of product safety and supply chain resilience is imperative for medtech founders. Increased recalls from a top player open doors to safer alternatives if you can move quickly.

Coverage

2 sources · first reported 5 Sep 2026 · latest 8 Sep 2026

Related on Wire

Topics

Medtechproduct-recallfdamedtechspinal-cord-implantboston-scientific